Lexaria Bioscience Corp. (LEXX) — Business segments and KPIs
Revenue by business segment and geography for Lexaria Bioscience Corp., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| IP Licensing | 696K | 98.6% |
| B2B | 9.92K | 1.4% |